Skip to main content

Indian Pharma Network

PRAXBIND (Idarucizumab) Injection

  • Medicine Name: PRAXBIND
  • Active Ingredient (API): Idarucizumab
  • Dosage Form & Strength: Injection: 2.5 g/50 mL x 2 vials
  • Manufactured By: Boehringer Ingelheim

Medical Uses

PRAXBIND (idarucizumab), from Boehringer Ingelheim, is indicated for the reversal of the anticoagulant effects of dabigatran (Pradaxa) in emergency surgery/urgent procedures or in life-threatening/uncontrolled bleeding.

Idarucizumab is a humanized monoclonal antibody fragment that binds dabigatran with high affinity, neutralizing its anticoagulant effect almost immediately, providing a targeted reversal agent distinct from general clotting-factor approaches.

Warnings & Precautions

  • Thromboembolic risk — patients are at risk for thrombotic events due to their underlying disease once anticoagulation is reversed; resumption of anticoagulant therapy should be considered as soon as medically appropriate.
  • Serious hypersensitivity reactions may occur.
  • Contains sorbitol — caution in patients with hereditary fructose intolerance.
  • Only reverses dabigatran; does not reverse other anticoagulants.

Documentation & Availability

What documents are required to import PRAXBIND to India?

PRAXBIND may be imported in the patient’s name only, by patients or government hospitals, and is typically stocked by hospitals for emergency use. The following documentation is required:

  • A valid prescription/order from a registered physician or hospital
  • Patient/hospital ID proof as applicable
How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription/hospital order, given the emergency nature of this product.

Is PRAXBIND available in India?

PRAXBIND is not commercially marketed in India. It can be legally accessed through the Named Patient Program (NPP) for hospital stocking or named-patient emergency use.

Sourcing & Delivery

Indian Pharma Network (IPN) can source PRAXBIND from its authorized distribution network and facilitate rapid supply to hospitals and patients under applicable legal provisions.

For PRAXBIND cost in India and availability, contact IPN at Phone: +91-9310090915 or email info@indianpharmanetwork.in.

Global Approval Status:

  • United States: Approved by the FDA — October 2015.

FAQ

What is PRAXBIND used for?

PRAXBIND rapidly reverses the anticoagulant effect of dabigatran (Pradaxa) in emergencies.

Who manufactures PRAXBIND?

PRAXBIND is developed by Boehringer Ingelheim.

How is PRAXBIND administered?

By intravenous injection or infusion, typically as two consecutive 2.5 g/50 mL doses.

How much does PRAXBIND cost in India?

Cost depends on quantity and urgency of sourcing logistics — contact IPN for a quote.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Product Enquiry